Sonio, the SaaS platform for healthcare professionals to secure prenatal care, has announced a €10M fundraising through the European Innovation Council Accelerator, the leading fund in supporting European deep-tech companies.
This fundraising (€2.5M in grant and €7.5M in equity investment) comes in addition to the €5M previously raised with Elaia, OneRagtime and Bpi France in June 2022. It will support Sonio to accelerate the release of new features on the platform, such as embedded image recognition and genomics.
Sonio brings together expertise from the fields of fetal medicine, artificial intelligence, software development and ultrasound imaging to address the 50% of congenital malformations that are not detected before birth and improve access and quality of care for pregnant women and children.
The startup also leverages 5 years of R&D and clinical development at Ecole Polytechnique, the PRAIRIE Institute and Necker Hospital in Paris, and provides a comprehensive solution to assist all fetal ultrasound practitioners, from beginners to the most seasoned experts.
Sonio’s multidisciplinary team has already brought 2 products to market:
Sonio Diagnostics, designed for expert diagnostic ultrasounds, was CE marked and found its first clients in record time.
Sonio Pro, tailored to secure and bring more efficiency to routine pregnancy ultrasounds, was launched in October and has already convinced customers in Europe.
Several partnerships have already been signed, with Samsung France, one of the main women’s health ultrasound manufacturers, but also with specialized distributors (Lifecell in India, Manager Systems in Brazil, Dynamic Medicals in Nigeria).
Join the HealthXL Webinar on ‘Retail Healthcare: Current and Future Opportunities for Digital Health’ on 26th January. Click here to Request to Join.
Click here to read the original news story.